Company intelligence / Profile preview

Hematech

Sioux Falls, South Dakota, USA
Ownership
Private
Development stage
Other
01

Overview

Hematech was a pioneering biotechnology company specializing in the development of human polyclonal antibodies through transgenic animal technology. Based in Sioux Falls, South Dakota, the company developed a unique "transchromosomic" (Tc) bovine platform, where cattle were genetically engineered to carry human immunoglobulin genes. This allowed the animals to produce high titers of fully human polyclonal antibodies in response to specific antigens, offering a powerful tool for treating infectious diseases and biothreats. Hematech was acquired by Kirin Brewery Company (later Kyowa Kirin) in 2005 to bolster their antibody research capabilities. The technology and personnel from Hematech later formed the foundation for SAB Biotherapeutics, which continues to advance the Tc bovine platform today.

Therapeutic areas
OncologyImmunologyInfectious Diseases
Modalities
AntibodyPolyclonal antibodiesRecombinant protein
Industry
Biotech
02

Partnerships

Kirin Brewery CompanySAB Biotherapeutics

Beyond the preview

Go deeper on Hematech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hematech.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call